|
|
市場調査レポート
商品コード
1519543
猫用ワクチンの世界市場規模、シェア、動向分析レポート:成分別、投与経路別、免疫期間別、疾患タイプ別、タイプ別、地域別、展望と予測、2024年~2031年Global Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Regional Outlook and Forecast, 2024 - 2031 |
||||||
|
|||||||
| 猫用ワクチンの世界市場規模、シェア、動向分析レポート:成分別、投与経路別、免疫期間別、疾患タイプ別、タイプ別、地域別、展望と予測、2024年~2031年 |
|
出版日: 2024年07月12日
発行: KBV Research
ページ情報: 英文 302 Pages
納期: 即納可能
|
全表示
- 概要
- 図表
- 目次
猫用ワクチン市場規模は、予測期間中に9.2%のCAGRで市場成長し、2031年までに25億米ドルに達すると予想されています。
さらに、猫をペットとして飼う世帯数の増加により、猫用ワクチンの需要が大幅に増加しています。この傾向は、都市化の進展、ライフスタイルの変化、ペットがもたらす精神的および交友関係の利点の認識の高まりなど、さまざまな要因の影響を受けています。国際動物福祉基金は、中国には5,800万匹の飼い猫が生息していると推定しており、アジアは世界最大の猫の生息地となっています。総人口6億人のうち4億匹が猫です。したがって、猫をペットとして飼う世帯数の増加により、猫用ワクチンの需要が増加しています。
しかし、知識不足は、公共の場でペットの健康に対する関心が一般的に欠如していること、健康キャンペーンの数が不十分であること、同時に獣医ケアへのアクセスが不十分であることなど、さまざまな問題に起因する可能性があります。多くの新興諸国では、獣医サービスは都市部に集中していることが多く、農村部や遠隔地のコミュニティでは専門家のアドバイスやサービスへのアクセスがほとんどありません。したがって、猫のワクチン接種の重要性に関する認識と教育の欠如は、猫用ワクチン市場の成長にとって大きな障害となっています。
さらに、パンデミックの初期段階では、間違いなく獣医ヘルスケアシステムに負担がかかった。ロックダウンやソーシャルディスタンス対策により、診療時間の短縮や臨時休業が頻繁に発生しました。その結果、猫の定期予防接種など、重要でない予約が延期またはキャンセルされた可能性が高いです。さらに、 COVID-19の動物用ワクチンの調査はまだ初期段階ではあるもの、将来的には猫用COVID-19ワクチンに特化した市場が生まれる可能性を示唆しています。したがって、パンデミックは市場に全体的に中程度の影響を及ぼしました。
タイプの展望
タイプに基づいて、市場は弱毒生、不活化(殺菌)、その他に分類されます。弱毒生セグメントは、2023年に市場で48%の収益シェアを獲得しました。弱毒生セグメントは、より少ない投与量で強力で長期的な免疫を提供できるため、猫用ワクチン市場をリードしています。これらのワクチンは強力な免疫反応を刺激し、猫ヘルペスウイルス(FHV)と猫カリシウイルス(FCV)に対して非常に効果的です。
疾患タイプの展望
病気タイプに基づいて、市場は猫白血病、猫汎白血球減少症(猫ジステンパー)、猫呼吸器疾患、猫狂犬病などに分類されます。猫白血病セグメントは、2023年に市場で10%の収益シェアを記録しました。猫白血病ウイルス(FeLV)は、免疫系への影響とがんを引き起こす能力により、飼い猫の主な死亡原因です。FeLVの深刻な性質と効果的なワクチンが利用可能であることから、ペットの飼い主はこの病気に対するワクチン接種を優先するようになりました。
投与経路の展望
投与経路別に見ると、市場は注射、経鼻、経口に分かれています。経鼻セグメントは、2023年に市場で15%の収益シェアを獲得しました。経鼻ワクチンは、猫ウイルス性鼻気管炎やカリシウイルスなどの呼吸器疾患に特に効果的です。これらのワクチンは、呼吸器系に局所免疫反応を誘発するという利点があり、鼻腔に侵入する病原体に対する強力な防御を提供します。
免疫期間の展望
免疫期間に基づいて、市場は1年、3年、その他に分類されます。1年セグメントは、2023年に市場で49%の収益シェアを獲得しました。これらのワクチンは通常、猫ウイルス性鼻気管炎、カリシウイルス、汎白血球減少症などのコアワクチン接種に使用され、効果的な免疫を維持するために毎年の追加接種が必要です。投与頻度により、猫は一般的な病気や重篤な病気から保護され続けるため、これらのワクチンは日常的な獣医ケアの定番となっています。
成分の展望
成分に基づいて、市場は混合ワクチンと単味ワクチンに分かれています。混合ワクチンセグメントは、2023年に市場で62%の収益シェアを記録しました。1回の投与で複数の病気から保護するこれらのワクチンは、その利便性と効率性が高く評価されています。混合ワクチンは、必要な注射回数を減らすことで、猫へのストレスを最小限に抑え、ペットの飼い主と獣医師のワクチン接種プロセスを簡素化します。
地域の展望
地域別に見ると、市場は北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカにわたって分析されています。北米セグメントは、2023年に市場で38%の収益シェアを獲得しました。この地域の優位性は、ペットの飼育率の高さ、高度な獣医ヘルスケアインフラ、ペットの健康とワクチン接種に対する強い意識によって推進されています。特に、米国とカナダには、定期的なペットのワクチン接種スケジュールを促進する強力な規制枠組みと公衆衛生キャンペーンがあります。
目次
第1章 市場範囲と調査手法
- 市場の定義
- 目的
- 市場範囲
- セグメンテーション
- 調査手法
第2章 市場要覧
- 主なハイライト
第3章 市場概要
- イントロダクション
- 概要
- 市場構成とシナリオ
- 概要
- 市場に影響を与える主な要因
- 市場促進要因
- 市場抑制要因
- 市場機会
- 市場の課題
- ポーターのファイブフォース分析
第4章 猫用ワクチン市場で展開される戦略
第5章 世界市場:成分別
- 世界の混合ワクチン市場:地域別
- 世界の単味ワクチン市場:地域別
第6章 世界市場:投与経路別
- 世界の注射市場:地域別
- 世界の経鼻市場:地域別
- 世界の経口市場:地域別
第7章 世界市場:免疫期間別
- 世界の1年市場:地域別
- 世界の3年市場:地域別
- 世界のその他の市場:地域別
第8章 世界市場:疾患タイプ別
- 世界の猫呼吸器疾患市場:地域別
- 世界の猫狂犬病市場:地域別
- 世界の猫汎白血球減少症(猫ジステンパー)市場:地域別
- 世界の猫白血病市場:地域別
- 世界のその他の市場:地域別
第9章 世界市場:タイプ別
- 世界の弱毒生市場:地域別
- 世界の不活化(殺菌)市場:地域別
- 世界のその他の市場:地域別
第10章 世界市場:地域別
- 北米
- 北米の市場:国別
- 米国
- カナダ
- メキシコ
- その他北米地域
- 北米の市場:国別
- 欧州
- 欧州の市場:国別
- ドイツ
- 英国
- フランス
- ロシア
- スペイン
- イタリア
- その他欧州地域
- 欧州の市場:国別
- アジア太平洋地域
- アジア太平洋の市場:国別
- 中国
- 日本
- インド
- 韓国
- シンガポール
- マレーシア
- その他アジア太平洋地域
- アジア太平洋の市場:国別
- ラテンアメリカ・中東・アフリカ
- ラテンアメリカ・中東・アフリカの市場:国別
- ブラジル
- アルゼンチン
- アラブ首長国連邦
- サウジアラビア
- 南アフリカ
- ナイジェリア
- その他ラテンアメリカ・中東・アフリカ地域
- ラテンアメリカ・中東・アフリカの市場:国別
第11章 企業プロファイル
- Zoetis, Inc
- Elanco Animal Health, Inc
- Merck & Co, Inc.
- Boehringer Ingelheim International GmbH
- Covetrus, Inc(Clayton, Dubilier & Rice, LLC)
- Virbac
- Heska Corporation(Antech Diagnostics, Inc)
- Ceva Sante Animale
- Bioveta, as
第12章 猫用ワクチン市場の成功必須条件
LIST OF TABLES
- TABLE 1 Global Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 2 Global Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 3 Global Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 4 Global Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 5 Global Combined Vaccines Market by Region, 2020 - 2023, USD Million
- TABLE 6 Global Combined Vaccines Market by Region, 2024 - 2031, USD Million
- TABLE 7 Global Mono Vaccines Market by Region, 2020 - 2023, USD Million
- TABLE 8 Global Mono Vaccines Market by Region, 2024 - 2031, USD Million
- TABLE 9 Global Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 10 Global Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 11 Global Injectables Market by Region, 2020 - 2023, USD Million
- TABLE 12 Global Injectables Market by Region, 2024 - 2031, USD Million
- TABLE 13 Global Intranasal Market by Region, 2020 - 2023, USD Million
- TABLE 14 Global Intranasal Market by Region, 2024 - 2031, USD Million
- TABLE 15 Global Oral Market by Region, 2020 - 2023, USD Million
- TABLE 16 Global Oral Market by Region, 2024 - 2031, USD Million
- TABLE 17 Global Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 18 Global Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 19 Global 1 Year Market by Region, 2020 - 2023, USD Million
- TABLE 20 Global 1 Year Market by Region, 2024 - 2031, USD Million
- TABLE 21 Global 3 Year Market by Region, 2020 - 2023, USD Million
- TABLE 22 Global 3 Year Market by Region, 2024 - 2031, USD Million
- TABLE 23 Global Others Market by Region, 2020 - 2023, USD Million
- TABLE 24 Global Others Market by Region, 2024 - 2031, USD Million
- TABLE 25 Global Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 26 Global Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 27 Global Feline Respiratory Diseases Market by Region, 2020 - 2023, USD Million
- TABLE 28 Global Feline Respiratory Diseases Market by Region, 2024 - 2031, USD Million
- TABLE 29 Global Feline Rabies Market by Region, 2020 - 2023, USD Million
- TABLE 30 Global Feline Rabies Market by Region, 2024 - 2031, USD Million
- TABLE 31 Global Feline Panleukopenia (Feline Distemper) Market by Region, 2020 - 2023, USD Million
- TABLE 32 Global Feline Panleukopenia (Feline Distemper) Market by Region, 2024 - 2031, USD Million
- TABLE 33 Global Feline Leukemia Market by Region, 2020 - 2023, USD Million
- TABLE 34 Global Feline Leukemia Market by Region, 2024 - 2031, USD Million
- TABLE 35 Global Others Market by Region, 2020 - 2023, USD Million
- TABLE 36 Global Others Market by Region, 2024 - 2031, USD Million
- TABLE 37 Global Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 38 Global Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 39 Global Modified/Attenuated Live Market by Region, 2020 - 2023, USD Million
- TABLE 40 Global Modified/Attenuated Live Market by Region, 2024 - 2031, USD Million
- TABLE 41 Global Inactivated (Killed) Market by Region, 2020 - 2023, USD Million
- TABLE 42 Global Inactivated (Killed) Market by Region, 2024 - 2031, USD Million
- TABLE 43 Global Others Market by Region, 2020 - 2023, USD Million
- TABLE 44 Global Others Market by Region, 2024 - 2031, USD Million
- TABLE 45 Global Cat Vaccine Market by Region, 2020 - 2023, USD Million
- TABLE 46 Global Cat Vaccine Market by Region, 2024 - 2031, USD Million
- TABLE 47 North America Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 48 North America Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 49 North America Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 50 North America Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 51 North America Combined Vaccines Market by Region, 2020 - 2023, USD Million
- TABLE 52 North America Combined Vaccines Market by Region, 2024 - 2031, USD Million
- TABLE 53 North America Mono Vaccines Market by Region, 2020 - 2023, USD Million
- TABLE 54 North America Mono Vaccines Market by Region, 2024 - 2031, USD Million
- TABLE 55 North America Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 56 North America Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 57 North America Injectables Market by Country, 2020 - 2023, USD Million
- TABLE 58 North America Injectables Market by Country, 2024 - 2031, USD Million
- TABLE 59 North America Intranasal Market by Country, 2020 - 2023, USD Million
- TABLE 60 North America Intranasal Market by Country, 2024 - 2031, USD Million
- TABLE 61 North America Oral Market by Country, 2020 - 2023, USD Million
- TABLE 62 North America Oral Market by Country, 2024 - 2031, USD Million
- TABLE 63 North America Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 64 North America Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 65 North America 1 Year Market by Country, 2020 - 2023, USD Million
- TABLE 66 North America 1 Year Market by Country, 2024 - 2031, USD Million
- TABLE 67 North America 3 Year Market by Country, 2020 - 2023, USD Million
- TABLE 68 North America 3 Year Market by Country, 2024 - 2031, USD Million
- TABLE 69 North America Others Market by Country, 2020 - 2023, USD Million
- TABLE 70 North America Others Market by Country, 2024 - 2031, USD Million
- TABLE 71 North America Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 72 North America Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 73 North America Feline Respiratory Diseases Market by Country, 2020 - 2023, USD Million
- TABLE 74 North America Feline Respiratory Diseases Market by Country, 2024 - 2031, USD Million
- TABLE 75 North America Feline Rabies Market by Country, 2020 - 2023, USD Million
- TABLE 76 North America Feline Rabies Market by Country, 2024 - 2031, USD Million
- TABLE 77 North America Feline Panleukopenia (Feline Distemper) Market by Country, 2020 - 2023, USD Million
- TABLE 78 North America Feline Panleukopenia (Feline Distemper) Market by Country, 2024 - 2031, USD Million
- TABLE 79 North America Feline Leukemia Market by Country, 2020 - 2023, USD Million
- TABLE 80 North America Feline Leukemia Market by Country, 2024 - 2031, USD Million
- TABLE 81 North America Others Market by Country, 2020 - 2023, USD Million
- TABLE 82 North America Others Market by Country, 2024 - 2031, USD Million
- TABLE 83 North America Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 84 North America Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 85 North America Modified/Attenuated Live Market by Country, 2020 - 2023, USD Million
- TABLE 86 North America Modified/Attenuated Live Market by Country, 2024 - 2031, USD Million
- TABLE 87 North America Inactivated (Killed) Market by Country, 2020 - 2023, USD Million
- TABLE 88 North America Inactivated (Killed) Market by Country, 2024 - 2031, USD Million
- TABLE 89 North America Others Market by Country, 2020 - 2023, USD Million
- TABLE 90 North America Others Market by Country, 2024 - 2031, USD Million
- TABLE 91 North America Cat Vaccine Market by Country, 2020 - 2023, USD Million
- TABLE 92 North America Cat Vaccine Market by Country, 2024 - 2031, USD Million
- TABLE 93 US Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 94 US Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 95 US Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 96 US Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 97 US Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 98 US Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 99 US Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 100 US Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 101 US Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 102 US Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 103 US Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 104 US Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 105 Canada Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 106 Canada Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 107 Canada Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 108 Canada Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 109 Canada Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 110 Canada Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 111 Canada Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 112 Canada Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 113 Canada Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 114 Canada Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 115 Canada Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 116 Canada Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 117 Mexico Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 118 Mexico Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 119 Mexico Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 120 Mexico Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 121 Mexico Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 122 Mexico Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 123 Mexico Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 124 Mexico Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 125 Mexico Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 126 Mexico Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 127 Mexico Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 128 Mexico Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 129 Rest of North America Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 130 Rest of North America Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 131 Rest of North America Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 132 Rest of North America Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 133 Rest of North America Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 134 Rest of North America Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 135 Rest of North America Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 136 Rest of North America Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 137 Rest of North America Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 138 Rest of North America Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 139 Rest of North America Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 140 Rest of North America Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 141 Europe Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 142 Europe Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 143 Europe Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 144 Europe Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 145 Europe Combined Vaccines Market by Country, 2020 - 2023, USD Million
- TABLE 146 Europe Combined Vaccines Market by Country, 2024 - 2031, USD Million
- TABLE 147 Europe Mono Vaccines Market by Country, 2020 - 2023, USD Million
- TABLE 148 Europe Mono Vaccines Market by Country, 2024 - 2031, USD Million
- TABLE 149 Europe Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 150 Europe Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 151 Europe Injectables Market by Country, 2020 - 2023, USD Million
- TABLE 152 Europe Injectables Market by Country, 2024 - 2031, USD Million
- TABLE 153 Europe Intranasal Market by Country, 2020 - 2023, USD Million
- TABLE 154 Europe Intranasal Market by Country, 2024 - 2031, USD Million
- TABLE 155 Europe Oral Market by Country, 2020 - 2023, USD Million
- TABLE 156 Europe Oral Market by Country, 2024 - 2031, USD Million
- TABLE 157 Europe Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 158 Europe Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 159 Europe 1 Year Market by Country, 2020 - 2023, USD Million
- TABLE 160 Europe 1 Year Market by Country, 2024 - 2031, USD Million
- TABLE 161 Europe 3 Year Market by Country, 2020 - 2023, USD Million
- TABLE 162 Europe 3 Year Market by Country, 2024 - 2031, USD Million
- TABLE 163 Europe Others Market by Country, 2020 - 2023, USD Million
- TABLE 164 Europe Others Market by Country, 2024 - 2031, USD Million
- TABLE 165 Europe Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 166 Europe Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 167 Europe Feline Respiratory Diseases Market by Country, 2020 - 2023, USD Million
- TABLE 168 Europe Feline Respiratory Diseases Market by Country, 2024 - 2031, USD Million
- TABLE 169 Europe Feline Rabies Market by Country, 2020 - 2023, USD Million
- TABLE 170 Europe Feline Rabies Market by Country, 2024 - 2031, USD Million
- TABLE 171 Europe Feline Panleukopenia (Feline Distemper) Market by Country, 2020 - 2023, USD Million
- TABLE 172 Europe Feline Panleukopenia (Feline Distemper) Market by Country, 2024 - 2031, USD Million
- TABLE 173 Europe Feline Leukemia Market by Country, 2020 - 2023, USD Million
- TABLE 174 Europe Feline Leukemia Market by Country, 2024 - 2031, USD Million
- TABLE 175 Europe Others Market by Country, 2020 - 2023, USD Million
- TABLE 176 Europe Others Market by Country, 2024 - 2031, USD Million
- TABLE 177 Europe Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 178 Europe Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 179 Europe Modified/Attenuated Live Market by Country, 2020 - 2023, USD Million
- TABLE 180 Europe Modified/Attenuated Live Market by Country, 2024 - 2031, USD Million
- TABLE 181 Europe Inactivated (Killed) Market by Country, 2020 - 2023, USD Million
- TABLE 182 Europe Inactivated (Killed) Market by Country, 2024 - 2031, USD Million
- TABLE 183 Europe Others Market by Country, 2020 - 2023, USD Million
- TABLE 184 Europe Others Market by Country, 2024 - 2031, USD Million
- TABLE 185 Europe Cat Vaccine Market by Country, 2020 - 2023, USD Million
- TABLE 186 Europe Cat Vaccine Market by Country, 2024 - 2031, USD Million
- TABLE 187 Germany Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 188 Germany Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 189 Germany Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 190 Germany Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 191 Germany Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 192 Germany Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 193 Germany Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 194 Germany Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 195 Germany Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 196 Germany Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 197 Germany Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 198 Germany Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 199 UK Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 200 UK Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 201 UK Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 202 UK Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 203 UK Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 204 UK Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 205 UK Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 206 UK Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 207 UK Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 208 UK Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 209 UK Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 210 UK Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 211 France Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 212 France Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 213 France Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 214 France Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 215 France Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 216 France Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 217 France Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 218 France Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 219 France Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 220 France Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 221 France Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 222 France Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 223 Russia Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 224 Russia Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 225 Russia Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 226 Russia Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 227 Russia Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 228 Russia Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 229 Russia Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 230 Russia Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 231 Russia Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 232 Russia Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 233 Russia Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 234 Russia Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 235 Spain Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 236 Spain Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 237 Spain Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 238 Spain Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 239 Spain Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 240 Spain Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 241 Spain Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 242 Spain Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 243 Spain Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 244 Spain Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 245 Spain Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 246 Spain Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 247 Italy Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 248 Italy Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 249 Italy Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 250 Italy Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 251 Italy Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 252 Italy Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 253 Italy Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 254 Italy Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 255 Italy Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 256 Italy Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 257 Italy Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 258 Italy Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 259 Rest of Europe Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 260 Rest of Europe Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 261 Rest of Europe Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 262 Rest of Europe Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 263 Rest of Europe Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 264 Rest of Europe Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 265 Rest of Europe Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 266 Rest of Europe Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 267 Rest of Europe Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 268 Rest of Europe Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 269 Rest of Europe Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 270 Rest of Europe Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 271 Asia Pacific Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 272 Asia Pacific Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 273 Asia Pacific Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 274 Asia Pacific Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 275 Asia Pacific Combined Vaccines Market by Country, 2020 - 2023, USD Million
- TABLE 276 Asia Pacific Combined Vaccines Market by Country, 2024 - 2031, USD Million
- TABLE 277 Asia Pacific Mono Vaccines Market by Country, 2020 - 2023, USD Million
- TABLE 278 Asia Pacific Mono Vaccines Market by Country, 2024 - 2031, USD Million
- TABLE 279 Asia Pacific Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 280 Asia Pacific Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 281 Asia Pacific Injectables Market by Country, 2020 - 2023, USD Million
- TABLE 282 Asia Pacific Injectables Market by Country, 2024 - 2031, USD Million
- TABLE 283 Asia Pacific Intranasal Market by Country, 2020 - 2023, USD Million
- TABLE 284 Asia Pacific Intranasal Market by Country, 2024 - 2031, USD Million
- TABLE 285 Asia Pacific Oral Market by Country, 2020 - 2023, USD Million
- TABLE 286 Asia Pacific Oral Market by Country, 2024 - 2031, USD Million
- TABLE 287 Asia Pacific Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 288 Asia Pacific Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 289 Asia Pacific 1 Year Market by Country, 2020 - 2023, USD Million
- TABLE 290 Asia Pacific 1 Year Market by Country, 2024 - 2031, USD Million
- TABLE 291 Asia Pacific 3 Year Market by Country, 2020 - 2023, USD Million
- TABLE 292 Asia Pacific 3 Year Market by Country, 2024 - 2031, USD Million
- TABLE 293 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
- TABLE 294 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
- TABLE 295 Asia Pacific Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 296 Asia Pacific Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 297 Asia Pacific Feline Respiratory Diseases Market by Country, 2020 - 2023, USD Million
- TABLE 298 Asia Pacific Feline Respiratory Diseases Market by Country, 2024 - 2031, USD Million
- TABLE 299 Asia Pacific Feline Rabies Market by Country, 2020 - 2023, USD Million
- TABLE 300 Asia Pacific Feline Rabies Market by Country, 2024 - 2031, USD Million
- TABLE 301 Asia Pacific Feline Panleukopenia (Feline Distemper) Market by Country, 2020 - 2023, USD Million
- TABLE 302 Asia Pacific Feline Panleukopenia (Feline Distemper) Market by Country, 2024 - 2031, USD Million
- TABLE 303 Asia Pacific Feline Leukemia Market by Country, 2020 - 2023, USD Million
- TABLE 304 Asia Pacific Feline Leukemia Market by Country, 2024 - 2031, USD Million
- TABLE 305 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
- TABLE 306 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
- TABLE 307 Asia Pacific Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 308 Asia Pacific Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 309 Asia Pacific Modified/Attenuated Live Market by Country, 2020 - 2023, USD Million
- TABLE 310 Asia Pacific Modified/Attenuated Live Market by Country, 2024 - 2031, USD Million
- TABLE 311 Asia Pacific Inactivated (Killed) Market by Country, 2020 - 2023, USD Million
- TABLE 312 Asia Pacific Inactivated (Killed) Market by Country, 2024 - 2031, USD Million
- TABLE 313 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
- TABLE 314 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
- TABLE 315 Asia Pacific Cat Vaccine Market by Country, 2020 - 2023, USD Million
- TABLE 316 Asia Pacific Cat Vaccine Market by Country, 2024 - 2031, USD Million
- TABLE 317 China Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 318 China Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 319 China Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 320 China Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 321 China Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 322 China Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 323 China Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 324 China Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 325 China Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 326 China Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 327 China Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 328 China Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 329 Japan Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 330 Japan Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 331 Japan Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 332 Japan Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 333 Japan Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 334 Japan Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 335 Japan Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 336 Japan Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 337 Japan Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 338 Japan Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 339 Japan Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 340 Japan Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 341 India Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 342 India Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 343 India Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 344 India Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 345 India Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 346 India Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 347 India Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 348 India Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 349 India Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 350 India Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 351 India Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 352 India Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 353 South Korea Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 354 South Korea Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 355 South Korea Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 356 South Korea Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 357 South Korea Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 358 South Korea Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 359 South Korea Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 360 South Korea Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 361 South Korea Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 362 South Korea Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 363 South Korea Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 364 South Korea Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 365 Singapore Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 366 Singapore Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 367 Singapore Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 368 Singapore Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 369 Singapore Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 370 Singapore Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 371 Singapore Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 372 Singapore Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 373 Singapore Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 374 Singapore Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 375 Singapore Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 376 Singapore Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 377 Malaysia Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 378 Malaysia Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 379 Malaysia Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 380 Malaysia Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 381 Malaysia Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 382 Malaysia Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 383 Malaysia Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 384 Malaysia Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 385 Malaysia Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 386 Malaysia Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 387 Malaysia Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 388 Malaysia Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 389 Rest of Asia Pacific Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 390 Rest of Asia Pacific Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 391 Rest of Asia Pacific Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 392 Rest of Asia Pacific Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 393 Rest of Asia Pacific Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 394 Rest of Asia Pacific Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 395 Rest of Asia Pacific Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 396 Rest of Asia Pacific Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 397 Rest of Asia Pacific Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 398 Rest of Asia Pacific Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 399 Rest of Asia Pacific Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 400 Rest of Asia Pacific Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 401 LAMEA Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 402 LAMEA Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 403 LAMEA Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 404 LAMEA Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 405 LAMEA Combined Vaccines Market by Country, 2020 - 2023, USD Million
- TABLE 406 LAMEA Combined Vaccines Market by Country, 2024 - 2031, USD Million
- TABLE 407 LAMEA Mono Vaccines Market by Country, 2020 - 2023, USD Million
- TABLE 408 LAMEA Mono Vaccines Market by Country, 2024 - 2031, USD Million
- TABLE 409 LAMEA Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 410 LAMEA Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 411 LAMEA Injectables Market by Country, 2020 - 2023, USD Million
- TABLE 412 LAMEA Injectables Market by Country, 2024 - 2031, USD Million
- TABLE 413 LAMEA Intranasal Market by Country, 2020 - 2023, USD Million
- TABLE 414 LAMEA Intranasal Market by Country, 2024 - 2031, USD Million
- TABLE 415 LAMEA Oral Market by Country, 2020 - 2023, USD Million
- TABLE 416 LAMEA Oral Market by Country, 2024 - 2031, USD Million
- TABLE 417 LAMEA Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 418 LAMEA Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 419 LAMEA 1 Year Market by Country, 2020 - 2023, USD Million
- TABLE 420 LAMEA 1 Year Market by Country, 2024 - 2031, USD Million
- TABLE 421 LAMEA 3 Year Market by Country, 2020 - 2023, USD Million
- TABLE 422 LAMEA 3 Year Market by Country, 2024 - 2031, USD Million
- TABLE 423 LAMEA Others Market by Country, 2020 - 2023, USD Million
- TABLE 424 LAMEA Others Market by Country, 2024 - 2031, USD Million
- TABLE 425 LAMEA Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 426 LAMEA Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 427 LAMEA Feline Respiratory Diseases Market by Country, 2020 - 2023, USD Million
- TABLE 428 LAMEA Feline Respiratory Diseases Market by Country, 2024 - 2031, USD Million
- TABLE 429 LAMEA Feline Rabies Market by Country, 2020 - 2023, USD Million
- TABLE 430 LAMEA Feline Rabies Market by Country, 2024 - 2031, USD Million
- TABLE 431 LAMEA Feline Panleukopenia (Feline Distemper) Market by Country, 2020 - 2023, USD Million
- TABLE 432 LAMEA Feline Panleukopenia (Feline Distemper) Market by Country, 2024 - 2031, USD Million
- TABLE 433 LAMEA Feline Leukemia Market by Country, 2020 - 2023, USD Million
- TABLE 434 LAMEA Feline Leukemia Market by Country, 2024 - 2031, USD Million
- TABLE 435 LAMEA Others Market by Country, 2020 - 2023, USD Million
- TABLE 436 LAMEA Others Market by Country, 2024 - 2031, USD Million
- TABLE 437 LAMEA Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 438 LAMEA Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 439 LAMEA Modified/Attenuated Live Market by Country, 2020 - 2023, USD Million
- TABLE 440 LAMEA Modified/Attenuated Live Market by Country, 2024 - 2031, USD Million
- TABLE 441 LAMEA Inactivated (Killed) Market by Country, 2020 - 2023, USD Million
- TABLE 442 LAMEA Inactivated (Killed) Market by Country, 2024 - 2031, USD Million
- TABLE 443 LAMEA Others Market by Country, 2020 - 2023, USD Million
- TABLE 444 LAMEA Others Market by Country, 2024 - 2031, USD Million
- TABLE 445 LAMEA Cat Vaccine Market by Country, 2020 - 2023, USD Million
- TABLE 446 LAMEA Cat Vaccine Market by Country, 2024 - 2031, USD Million
- TABLE 447 Brazil Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 448 Brazil Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 449 Brazil Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 450 Brazil Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 451 Brazil Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 452 Brazil Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 453 Brazil Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 454 Brazil Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 455 Brazil Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 456 Brazil Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 457 Brazil Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 458 Brazil Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 459 Argentina Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 460 Argentina Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 461 Argentina Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 462 Argentina Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 463 Argentina Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 464 Argentina Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 465 Argentina Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 466 Argentina Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 467 Argentina Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 468 Argentina Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 469 Argentina Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 470 Argentina Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 471 UAE Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 472 UAE Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 473 UAE Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 474 UAE Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 475 UAE Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 476 UAE Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 477 UAE Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 478 UAE Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 479 UAE Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 480 UAE Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 481 UAE Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 482 UAE Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 483 Saudi Arabia Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 484 Saudi Arabia Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 485 Saudi Arabia Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 486 Saudi Arabia Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 487 Saudi Arabia Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 488 Saudi Arabia Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 489 Saudi Arabia Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 490 Saudi Arabia Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 491 Saudi Arabia Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 492 Saudi Arabia Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 493 Saudi Arabia Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 494 Saudi Arabia Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 495 South Africa Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 496 South Africa Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 497 South Africa Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 498 South Africa Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 499 South Africa Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 500 South Africa Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 501 South Africa Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 502 South Africa Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 503 South Africa Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 504 South Africa Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 505 South Africa Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 506 South Africa Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 507 Nigeria Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 508 Nigeria Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 509 Nigeria Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 510 Nigeria Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 511 Nigeria Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 512 Nigeria Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 513 Nigeria Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 514 Nigeria Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 515 Nigeria Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 516 Nigeria Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 517 Nigeria Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 518 Nigeria Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 519 Rest of LAMEA Cat Vaccine Market, 2020 - 2023, USD Million
- TABLE 520 Rest of LAMEA Cat Vaccine Market, 2024 - 2031, USD Million
- TABLE 521 Rest of LAMEA Cat Vaccine Market by Component, 2020 - 2023, USD Million
- TABLE 522 Rest of LAMEA Cat Vaccine Market by Component, 2024 - 2031, USD Million
- TABLE 523 Rest of LAMEA Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
- TABLE 524 Rest of LAMEA Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
- TABLE 525 Rest of LAMEA Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
- TABLE 526 Rest of LAMEA Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
- TABLE 527 Rest of LAMEA Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
- TABLE 528 Rest of LAMEA Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
- TABLE 529 Rest of LAMEA Cat Vaccine Market by Type, 2020 - 2023, USD Million
- TABLE 530 Rest of LAMEA Cat Vaccine Market by Type, 2024 - 2031, USD Million
- TABLE 531 Key Information - Zoetis, Inc.
- TABLE 532 Key information - Elanco Animal Health, Inc.
- TABLE 533 Key Information - Merck & Co., Inc.
- TABLE 534 Key Information - Boehringer Ingelheim International GmbH
- TABLE 535 Key Information - Covetrus, Inc.
- TABLE 536 Key Information - Virbac
- TABLE 537 Key Information - Heska Corporation
- TABLE 538 Key Information - Ceva SantE Animale
- TABLE 539 Key Information - Bioveta, a.s.
The Global Cat Vaccine Market size is expected to reach $2.5 billion by 2031, rising at a market growth of 9.2% CAGR during the forecast period.
The United Kingdom, Germany, and France have strict animal health regulations that require regular vaccinations, which contributes to the high compliance rates among pet owners. According to CATS REPORT 2022 published by Cats Protection, cat ownership levels vary across the UK, ranging from 24% of households in Scotland owning one or more cats to 28% of households in Wales. The growing trend of adopting stray and rescued cats, which require thorough vaccination schedules, further boosts the market in this region. Thus, the Europe region is expected to capture more than 1/4th revenue share in the market by the year 2031. A well-established veterinary care system and high levels of pet ownership support Europe's market. Additionally, the market demand is stimulated by the extensive awareness campaigns that European veterinary associations and government bodies conduct to educate pet owners about the significance of vaccinations.
The increasing prevalence of feline diseases has become a significant concern for pet owners, veterinarians, and public health officials. Among the most notable diseases are the feline leukemia virus (FeLV), feline immunodeficiency virus (FIV), and rabies, all of which pose serious threats to the health and well-being of cats. This rise in disease incidence has heightened the urgency for effective vaccination programs to prevent potential outbreaks. Veterinarians also advocate for regular vaccination schedules to safeguard cats against these prevalent diseases. Therefore, the increasing prevalence of feline diseases has raised the demand for cat vaccines.
Additionally, the rising number of households adopting cats as pets has significantly increased the demand for cat vaccines. This tendency is affected by a number of different variables, including the growing urbanization, the shifting lifestyles, and the growing realization of the mental and companionship benefits that pets provide. The International Fund for Animal Welfare estimates that China is home to 58 million domestic cats, making Asia the home of the largest population of cats in the world, which accounts for 400 million out of a total population of 600 million. Hence, the increasing number of households adopting cats as pets has increased the demand for cat vaccines.
However, the lack of knowledge can be attributed to a variety of various problems, such as a general lack of concern for the health of pets in public discourse, an inadequate number of health campaigns, and an inadequate amount of access to veterinary care at the same time. In many developing countries, veterinary services are often concentrated in urban areas, leaving rural and remote communities with minimal access to professional advice and services. Hence, the lack of awareness and education about the importance of cat vaccinations is a significant obstacle to the growth of the cat vaccine market.
Moreover, the early stages of the pandemic undoubtedly caused a strain on the veterinary healthcare system. Lockdowns and social distancing measures often led to reduced clinic hours or temporary closures. This, in turn, likely resulted in a postponement or cancellation of non-essential appointments, including routine vaccinations for cats. Moreover, research into animal vaccines for COVID-19, while still in its early stages, suggests the potential for a future market dedicated specifically to cat COVID-19 vaccines. Thus, the pandemic had an overall moderate impact on the market.
Type Outlook
Based on type, the market is characterized into modified/attenuated live, inactivated (killed), and others. The modified/attenuated live segment garnered 48% revenue share in the market in 2023. The modified/attenuated live vaccine segment leads the cat vaccine market due to its ability to provide strong and long-lasting immunity with fewer doses. These vaccines stimulate a robust immune response, making them highly effective against feline herpesvirus (FHV) and feline calicivirus (FCV).
Disease Type Outlook
On the basis of disease type, the market is classified into feline leukemia, feline panleukopenia (feline distemper), feline respiratory diseases, feline rabies, and others. The feline leukemia segment recorded 10% revenue share in the market in 2023. Feline leukemia virus (FeLV) is a leading cause of death in domestic cats due to its impact on the immune system and its ability to cause cancer. The serious nature of FeLV and the availability of effective vaccines have driven pet owners to prioritize vaccination against this disease.
Route of Administration Outlook
By route of administration, the market is divided into injectables, intranasal, and oral. The intranasal segment garnered 15% revenue share in the market in 2023. Intranasal vaccines are particularly effective for respiratory diseases such as feline viral rhinotracheitis and calicivirus. These vaccines offer the advantage of inducing a local immune response in the respiratory tract, providing robust protection against pathogens that enter the nasal passages.
Duration of Immunity Outlook
Based on duration of immunity, the market is segmented into 1 year, 3 year, and others. The 1 year segment procured 49% revenue share in the market in 2023. These vaccines are typically used for core vaccinations such as feline viral rhinotracheitis, calicivirus, and panleukopenia, which require annual boosters to maintain effective immunity. The frequency of administration ensures that cats remain protected against common and potentially severe diseases, making these vaccines a staple in routine veterinary care.
Component Outlook
On the basis of component, the market is bifurcated into combined vaccines and mono vaccines. The combined vaccines segment recorded 62% revenue share in the market in 2023. These vaccines, which protect against multiple diseases in a single dose, are highly valued for their convenience and efficiency. By reducing the number of injections required, combined vaccines minimize the stress on cats and simplify the vaccination process for pet owners and veterinarians.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered 38% revenue share in the market in 2023. This region's dominance is driven by a high rate of pet ownership, advanced veterinary healthcare infrastructure, and strong awareness about pet health and vaccinations. In particular, the United States and Canada have robust regulatory frameworks and public health campaigns promoting regular pet vaccination schedules.
Recent Strategies Deployed in the Market
- May-2024: Boehringer Ingelheim has announced the approval of SENVELGO(TM) (velagliflozin oral solution) by Health Canada for the treatment of feline diabetes. This milestone signifies a significant advancement in the management of diabetes mellitus in cats within Canada. SENVELGO(TM), a liquid oral solution, introduces a revolutionary approach that eliminates the necessity for needles, thereby simplifying the treatment process for cats previously untreated with insulin. This innovation aims to enhance glycemic control and improve the overall management of feline diabetes, offering a more convenient and accessible treatment option for pet owners and veterinarians alike.
- Apr-2024: Zoetis launched Bonqat(R) (pregabalin oral solution) across veterinary clinics in the U.S. This introduction enhances Zoetis's range of products aimed at improving feline health, made available through an exclusive agreement with Orion Corporation. Bonqat represents a distinctive advancement in cat care, simplifying the process for pet owners to bring their cats to veterinary appointments. Additionally, it encourages more thorough care at clinics, encompassing diagnostics and preventative measures such as flea treatment, parasite control, and vaccination.
- Apr-2024: Virbac acquired Sasaeah, a leading animal health player in Japan. We successfully completed the acquisition of Sasaeah. This strategic acquisition brings Virbac a leadership position in the farm animal vaccines market in Japan, notably in the cattle segment, and a large portfolio of pharmaceutical products for all the major species.
- Sep-2022: Zoetis took over NewMetrica, develops health-related quality of life instruments, integrating health-related quality of life instruments into its companion animal portfolio. This strategic move aims to bolster capabilities throughout the care spectrum, deepen expertise in quality-of-life evaluations, and foster a deeper understanding of animal well-being. The addition of NewMetrica's tools and algorithms is anticipated to facilitate early disease detection and treatment, providing invaluable insights into the quality of life of pets. These advancements will play a crucial role in future product development efforts. The acquisition aligns closely with Zoetis's mission to enhance animal care, reflecting its commitment to promoting the well-being of animals and contributing positively to society and the environment.
- Sep-2022: Zoetis Inc. revealed Solensia(TM) (frunevetmab injection) throughout the U.S. This marks a significant advancement in pet pain management, particularly for osteoarthritis (OA). Solensia(TM) offers a groundbreaking approach by providing relief from OA pain through a single monthly injection administered directly in the veterinary clinic. This innovation aims to minimize the impact of OA pain, preserving the special bond between cats and their human companions without disruption. Zoetis is committed to collaborating closely with veterinarians to introduce this novel monoclonal antibody treatment, enhancing the quality of life for cats and supporting their well-being through effective and convenient pain management solutions.
List of Key Companies Profiled
- Zoetis, Inc.
- Elanco Animal Health, Inc.
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- Virbac
- Heska Corporation (Antech Diagnostics, Inc)
- Ceva Sante Animale
- Bioveta, a.s.
Global Cat Vaccine Market Report Segmentation
By Component
- Combined Vaccines
- Mono Vaccines
By Route of Administration
- Injectables
- Intranasal
- Oral
By Duration of Immunity
- 1 Year
- 3 Year
- Others
By Disease Type
- Feline Respiratory Diseases
- Feline Rabies
- Feline Panleukopenia (Feline Distemper)
- Feline Leukemia
- Others
By Type
- Modified/Attenuated Live
- Inactivated (Killed)
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global Cat Vaccine Market, by Component
- 1.4.2 Global Cat Vaccine Market, by Route of Administration
- 1.4.3 Global Cat Vaccine Market, by Duration of Immunity
- 1.4.4 Global Cat Vaccine Market, by Disease Type
- 1.4.5 Global Cat Vaccine Market, by Type
- 1.4.6 Global Cat Vaccine Market, by Geography
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Cat Vaccine Market
Chapter 5. Global Cat Vaccine Market by Component
- 5.1 Global Combined Vaccines Market by Region
- 5.2 Global Mono Vaccines Market by Region
Chapter 6. Global Cat Vaccine Market by Route of Administration
- 6.1 Global Injectables Market by Region
- 6.2 Global Intranasal Market by Region
- 6.3 Global Oral Market by Region
Chapter 7. Global Cat Vaccine Market by Duration of Immunity
- 7.1 Global 1 Year Market by Region
- 7.2 Global 3 Year Market by Region
- 7.3 Global Others Market by Region
Chapter 8. Global Cat Vaccine Market by Disease Type
- 8.1 Global Feline Respiratory Diseases Market by Region
- 8.2 Global Feline Rabies Market by Region
- 8.3 Global Feline Panleukopenia (Feline Distemper) Market by Region
- 8.4 Global Feline Leukemia Market by Region
- 8.5 Global Others Market by Region
Chapter 9. Global Cat Vaccine Market by Type
- 9.1 Global Modified/Attenuated Live Market by Region
- 9.2 Global Inactivated (Killed) Market by Region
- 9.3 Global Others Market by Region
Chapter 10. Global Cat Vaccine Market by Region
- 10.1 North America Cat Vaccine Market
- 10.1.1 North America Cat Vaccine Market by Component
- 10.1.1.1 North America Combined Vaccines Market by Region
- 10.1.1.2 North America Mono Vaccines Market by Region
- 10.1.2 North America Cat Vaccine Market by Route of Administration
- 10.1.2.1 North America Injectables Market by Country
- 10.1.2.2 North America Intranasal Market by Country
- 10.1.2.3 North America Oral Market by Country
- 10.1.3 North America Cat Vaccine Market by Duration of Immunity
- 10.1.3.1 North America 1 Year Market by Country
- 10.1.3.2 North America 3 Year Market by Country
- 10.1.3.3 North America Others Market by Country
- 10.1.4 North America Cat Vaccine Market by Disease Type
- 10.1.4.1 North America Feline Respiratory Diseases Market by Country
- 10.1.4.2 North America Feline Rabies Market by Country
- 10.1.4.3 North America Feline Panleukopenia (Feline Distemper) Market by Country
- 10.1.4.4 North America Feline Leukemia Market by Country
- 10.1.4.5 North America Others Market by Country
- 10.1.5 North America Cat Vaccine Market by Type
- 10.1.5.1 North America Modified/Attenuated Live Market by Country
- 10.1.5.2 North America Inactivated (Killed) Market by Country
- 10.1.5.3 North America Others Market by Country
- 10.1.6 North America Cat Vaccine Market by Country
- 10.1.6.1 US Cat Vaccine Market
- 10.1.6.1.1 US Cat Vaccine Market by Component
- 10.1.6.1.2 US Cat Vaccine Market by Route of Administration
- 10.1.6.1.3 US Cat Vaccine Market by Duration of Immunity
- 10.1.6.1.4 US Cat Vaccine Market by Disease Type
- 10.1.6.1.5 US Cat Vaccine Market by Type
- 10.1.6.2 Canada Cat Vaccine Market
- 10.1.6.2.1 Canada Cat Vaccine Market by Component
- 10.1.6.2.2 Canada Cat Vaccine Market by Route of Administration
- 10.1.6.2.3 Canada Cat Vaccine Market by Duration of Immunity
- 10.1.6.2.4 Canada Cat Vaccine Market by Disease Type
- 10.1.6.2.5 Canada Cat Vaccine Market by Type
- 10.1.6.3 Mexico Cat Vaccine Market
- 10.1.6.3.1 Mexico Cat Vaccine Market by Component
- 10.1.6.3.2 Mexico Cat Vaccine Market by Route of Administration
- 10.1.6.3.3 Mexico Cat Vaccine Market by Duration of Immunity
- 10.1.6.3.4 Mexico Cat Vaccine Market by Disease Type
- 10.1.6.3.5 Mexico Cat Vaccine Market by Type
- 10.1.6.4 Rest of North America Cat Vaccine Market
- 10.1.6.4.1 Rest of North America Cat Vaccine Market by Component
- 10.1.6.4.2 Rest of North America Cat Vaccine Market by Route of Administration
- 10.1.6.4.3 Rest of North America Cat Vaccine Market by Duration of Immunity
- 10.1.6.4.4 Rest of North America Cat Vaccine Market by Disease Type
- 10.1.6.4.5 Rest of North America Cat Vaccine Market by Type
- 10.1.6.1 US Cat Vaccine Market
- 10.1.1 North America Cat Vaccine Market by Component
- 10.2 Europe Cat Vaccine Market
- 10.2.1 Europe Cat Vaccine Market by Component
- 10.2.1.1 Europe Combined Vaccines Market by Country
- 10.2.1.2 Europe Mono Vaccines Market by Country
- 10.2.2 Europe Cat Vaccine Market by Route of Administration
- 10.2.2.1 Europe Injectables Market by Country
- 10.2.2.2 Europe Intranasal Market by Country
- 10.2.2.3 Europe Oral Market by Country
- 10.2.3 Europe Cat Vaccine Market by Duration of Immunity
- 10.2.3.1 Europe 1 Year Market by Country
- 10.2.3.2 Europe 3 Year Market by Country
- 10.2.3.3 Europe Others Market by Country
- 10.2.4 Europe Cat Vaccine Market by Disease Type
- 10.2.4.1 Europe Feline Respiratory Diseases Market by Country
- 10.2.4.2 Europe Feline Rabies Market by Country
- 10.2.4.3 Europe Feline Panleukopenia (Feline Distemper) Market by Country
- 10.2.4.4 Europe Feline Leukemia Market by Country
- 10.2.4.5 Europe Others Market by Country
- 10.2.5 Europe Cat Vaccine Market by Type
- 10.2.5.1 Europe Modified/Attenuated Live Market by Country
- 10.2.5.2 Europe Inactivated (Killed) Market by Country
- 10.2.5.3 Europe Others Market by Country
- 10.2.6 Europe Cat Vaccine Market by Country
- 10.2.6.1 Germany Cat Vaccine Market
- 10.2.6.1.1 Germany Cat Vaccine Market by Component
- 10.2.6.1.2 Germany Cat Vaccine Market by Route of Administration
- 10.2.6.1.3 Germany Cat Vaccine Market by Duration of Immunity
- 10.2.6.1.4 Germany Cat Vaccine Market by Disease Type
- 10.2.6.1.5 Germany Cat Vaccine Market by Type
- 10.2.6.2 UK Cat Vaccine Market
- 10.2.6.2.1 UK Cat Vaccine Market by Component
- 10.2.6.2.2 UK Cat Vaccine Market by Route of Administration
- 10.2.6.2.3 UK Cat Vaccine Market by Duration of Immunity
- 10.2.6.2.4 UK Cat Vaccine Market by Disease Type
- 10.2.6.2.5 UK Cat Vaccine Market by Type
- 10.2.6.3 France Cat Vaccine Market
- 10.2.6.3.1 France Cat Vaccine Market by Component
- 10.2.6.3.2 France Cat Vaccine Market by Route of Administration
- 10.2.6.3.3 France Cat Vaccine Market by Duration of Immunity
- 10.2.6.3.4 France Cat Vaccine Market by Disease Type
- 10.2.6.3.5 France Cat Vaccine Market by Type
- 10.2.6.4 Russia Cat Vaccine Market
- 10.2.6.4.1 Russia Cat Vaccine Market by Component
- 10.2.6.4.2 Russia Cat Vaccine Market by Route of Administration
- 10.2.6.4.3 Russia Cat Vaccine Market by Duration of Immunity
- 10.2.6.4.4 Russia Cat Vaccine Market by Disease Type
- 10.2.6.4.5 Russia Cat Vaccine Market by Type
- 10.2.6.5 Spain Cat Vaccine Market
- 10.2.6.5.1 Spain Cat Vaccine Market by Component
- 10.2.6.5.2 Spain Cat Vaccine Market by Route of Administration
- 10.2.6.5.3 Spain Cat Vaccine Market by Duration of Immunity
- 10.2.6.5.4 Spain Cat Vaccine Market by Disease Type
- 10.2.6.5.5 Spain Cat Vaccine Market by Type
- 10.2.6.6 Italy Cat Vaccine Market
- 10.2.6.6.1 Italy Cat Vaccine Market by Component
- 10.2.6.6.2 Italy Cat Vaccine Market by Route of Administration
- 10.2.6.6.3 Italy Cat Vaccine Market by Duration of Immunity
- 10.2.6.6.4 Italy Cat Vaccine Market by Disease Type
- 10.2.6.6.5 Italy Cat Vaccine Market by Type
- 10.2.6.7 Rest of Europe Cat Vaccine Market
- 10.2.6.7.1 Rest of Europe Cat Vaccine Market by Component
- 10.2.6.7.2 Rest of Europe Cat Vaccine Market by Route of Administration
- 10.2.6.7.3 Rest of Europe Cat Vaccine Market by Duration of Immunity
- 10.2.6.7.4 Rest of Europe Cat Vaccine Market by Disease Type
- 10.2.6.7.5 Rest of Europe Cat Vaccine Market by Type
- 10.2.6.1 Germany Cat Vaccine Market
- 10.2.1 Europe Cat Vaccine Market by Component
- 10.3 Asia Pacific Cat Vaccine Market
- 10.3.1 Asia Pacific Cat Vaccine Market by Component
- 10.3.1.1 Asia Pacific Combined Vaccines Market by Country
- 10.3.1.2 Asia Pacific Mono Vaccines Market by Country
- 10.3.2 Asia Pacific Cat Vaccine Market by Route of Administration
- 10.3.2.1 Asia Pacific Injectables Market by Country
- 10.3.2.2 Asia Pacific Intranasal Market by Country
- 10.3.2.3 Asia Pacific Oral Market by Country
- 10.3.3 Asia Pacific Cat Vaccine Market by Duration of Immunity
- 10.3.3.1 Asia Pacific 1 Year Market by Country
- 10.3.3.2 Asia Pacific 3 Year Market by Country
- 10.3.3.3 Asia Pacific Others Market by Country
- 10.3.4 Asia Pacific Cat Vaccine Market by Disease Type
- 10.3.4.1 Asia Pacific Feline Respiratory Diseases Market by Country
- 10.3.4.2 Asia Pacific Feline Rabies Market by Country
- 10.3.4.3 Asia Pacific Feline Panleukopenia (Feline Distemper) Market by Country
- 10.3.4.4 Asia Pacific Feline Leukemia Market by Country
- 10.3.4.5 Asia Pacific Others Market by Country
- 10.3.5 Asia Pacific Cat Vaccine Market by Type
- 10.3.5.1 Asia Pacific Modified/Attenuated Live Market by Country
- 10.3.5.2 Asia Pacific Inactivated (Killed) Market by Country
- 10.3.5.3 Asia Pacific Others Market by Country
- 10.3.6 Asia Pacific Cat Vaccine Market by Country
- 10.3.6.1 China Cat Vaccine Market
- 10.3.6.1.1 China Cat Vaccine Market by Component
- 10.3.6.1.2 China Cat Vaccine Market by Route of Administration
- 10.3.6.1.3 China Cat Vaccine Market by Duration of Immunity
- 10.3.6.1.4 China Cat Vaccine Market by Disease Type
- 10.3.6.1.5 China Cat Vaccine Market by Type
- 10.3.6.2 Japan Cat Vaccine Market
- 10.3.6.2.1 Japan Cat Vaccine Market by Component
- 10.3.6.2.2 Japan Cat Vaccine Market by Route of Administration
- 10.3.6.2.3 Japan Cat Vaccine Market by Duration of Immunity
- 10.3.6.2.4 Japan Cat Vaccine Market by Disease Type
- 10.3.6.2.5 Japan Cat Vaccine Market by Type
- 10.3.6.3 India Cat Vaccine Market
- 10.3.6.3.1 India Cat Vaccine Market by Component
- 10.3.6.3.2 India Cat Vaccine Market by Route of Administration
- 10.3.6.3.3 India Cat Vaccine Market by Duration of Immunity
- 10.3.6.3.4 India Cat Vaccine Market by Disease Type
- 10.3.6.3.5 India Cat Vaccine Market by Type
- 10.3.6.4 South Korea Cat Vaccine Market
- 10.3.6.4.1 South Korea Cat Vaccine Market by Component
- 10.3.6.4.2 South Korea Cat Vaccine Market by Route of Administration
- 10.3.6.4.3 South Korea Cat Vaccine Market by Duration of Immunity
- 10.3.6.4.4 South Korea Cat Vaccine Market by Disease Type
- 10.3.6.4.5 South Korea Cat Vaccine Market by Type
- 10.3.6.5 Singapore Cat Vaccine Market
- 10.3.6.5.1 Singapore Cat Vaccine Market by Component
- 10.3.6.5.2 Singapore Cat Vaccine Market by Route of Administration
- 10.3.6.5.3 Singapore Cat Vaccine Market by Duration of Immunity
- 10.3.6.5.4 Singapore Cat Vaccine Market by Disease Type
- 10.3.6.5.5 Singapore Cat Vaccine Market by Type
- 10.3.6.6 Malaysia Cat Vaccine Market
- 10.3.6.6.1 Malaysia Cat Vaccine Market by Component
- 10.3.6.6.2 Malaysia Cat Vaccine Market by Route of Administration
- 10.3.6.6.3 Malaysia Cat Vaccine Market by Duration of Immunity
- 10.3.6.6.4 Malaysia Cat Vaccine Market by Disease Type
- 10.3.6.6.5 Malaysia Cat Vaccine Market by Type
- 10.3.6.7 Rest of Asia Pacific Cat Vaccine Market
- 10.3.6.7.1 Rest of Asia Pacific Cat Vaccine Market by Component
- 10.3.6.7.2 Rest of Asia Pacific Cat Vaccine Market by Route of Administration
- 10.3.6.7.3 Rest of Asia Pacific Cat Vaccine Market by Duration of Immunity
- 10.3.6.7.4 Rest of Asia Pacific Cat Vaccine Market by Disease Type
- 10.3.6.7.5 Rest of Asia Pacific Cat Vaccine Market by Type
- 10.3.6.1 China Cat Vaccine Market
- 10.3.1 Asia Pacific Cat Vaccine Market by Component
- 10.4 LAMEA Cat Vaccine Market
- 10.4.1 LAMEA Cat Vaccine Market by Component
- 10.4.1.1 LAMEA Combined Vaccines Market by Country
- 10.4.1.2 LAMEA Mono Vaccines Market by Country
- 10.4.2 LAMEA Cat Vaccine Market by Route of Administration
- 10.4.2.1 LAMEA Injectables Market by Country
- 10.4.2.2 LAMEA Intranasal Market by Country
- 10.4.2.3 LAMEA Oral Market by Country
- 10.4.3 LAMEA Cat Vaccine Market by Duration of Immunity
- 10.4.3.1 LAMEA 1 Year Market by Country
- 10.4.3.2 LAMEA 3 Year Market by Country
- 10.4.3.3 LAMEA Others Market by Country
- 10.4.4 LAMEA Cat Vaccine Market by Disease Type
- 10.4.4.1 LAMEA Feline Respiratory Diseases Market by Country
- 10.4.4.2 LAMEA Feline Rabies Market by Country
- 10.4.4.3 LAMEA Feline Panleukopenia (Feline Distemper) Market by Country
- 10.4.4.4 LAMEA Feline Leukemia Market by Country
- 10.4.4.5 LAMEA Others Market by Country
- 10.4.5 LAMEA Cat Vaccine Market by Type
- 10.4.5.1 LAMEA Modified/Attenuated Live Market by Country
- 10.4.5.2 LAMEA Inactivated (Killed) Market by Country
- 10.4.5.3 LAMEA Others Market by Country
- 10.4.6 LAMEA Cat Vaccine Market by Country
- 10.4.6.1 Brazil Cat Vaccine Market
- 10.4.6.1.1 Brazil Cat Vaccine Market by Component
- 10.4.6.1.2 Brazil Cat Vaccine Market by Route of Administration
- 10.4.6.1.3 Brazil Cat Vaccine Market by Duration of Immunity
- 10.4.6.1.4 Brazil Cat Vaccine Market by Disease Type
- 10.4.6.1.5 Brazil Cat Vaccine Market by Type
- 10.4.6.2 Argentina Cat Vaccine Market
- 10.4.6.2.1 Argentina Cat Vaccine Market by Component
- 10.4.6.2.2 Argentina Cat Vaccine Market by Route of Administration
- 10.4.6.2.3 Argentina Cat Vaccine Market by Duration of Immunity
- 10.4.6.2.4 Argentina Cat Vaccine Market by Disease Type
- 10.4.6.2.5 Argentina Cat Vaccine Market by Type
- 10.4.6.3 UAE Cat Vaccine Market
- 10.4.6.3.1 UAE Cat Vaccine Market by Component
- 10.4.6.3.2 UAE Cat Vaccine Market by Route of Administration
- 10.4.6.3.3 UAE Cat Vaccine Market by Duration of Immunity
- 10.4.6.3.4 UAE Cat Vaccine Market by Disease Type
- 10.4.6.3.5 UAE Cat Vaccine Market by Type
- 10.4.6.4 Saudi Arabia Cat Vaccine Market
- 10.4.6.4.1 Saudi Arabia Cat Vaccine Market by Component
- 10.4.6.4.2 Saudi Arabia Cat Vaccine Market by Route of Administration
- 10.4.6.4.3 Saudi Arabia Cat Vaccine Market by Duration of Immunity
- 10.4.6.4.4 Saudi Arabia Cat Vaccine Market by Disease Type
- 10.4.6.4.5 Saudi Arabia Cat Vaccine Market by Type
- 10.4.6.5 South Africa Cat Vaccine Market
- 10.4.6.5.1 South Africa Cat Vaccine Market by Component
- 10.4.6.5.2 South Africa Cat Vaccine Market by Route of Administration
- 10.4.6.5.3 South Africa Cat Vaccine Market by Duration of Immunity
- 10.4.6.5.4 South Africa Cat Vaccine Market by Disease Type
- 10.4.6.5.5 South Africa Cat Vaccine Market by Type
- 10.4.6.6 Nigeria Cat Vaccine Market
- 10.4.6.6.1 Nigeria Cat Vaccine Market by Component
- 10.4.6.6.2 Nigeria Cat Vaccine Market by Route of Administration
- 10.4.6.6.3 Nigeria Cat Vaccine Market by Duration of Immunity
- 10.4.6.6.4 Nigeria Cat Vaccine Market by Disease Type
- 10.4.6.6.5 Nigeria Cat Vaccine Market by Type
- 10.4.6.7 Rest of LAMEA Cat Vaccine Market
- 10.4.6.7.1 Rest of LAMEA Cat Vaccine Market by Component
- 10.4.6.7.2 Rest of LAMEA Cat Vaccine Market by Route of Administration
- 10.4.6.7.3 Rest of LAMEA Cat Vaccine Market by Duration of Immunity
- 10.4.6.7.4 Rest of LAMEA Cat Vaccine Market by Disease Type
- 10.4.6.7.5 Rest of LAMEA Cat Vaccine Market by Type
- 10.4.6.1 Brazil Cat Vaccine Market
- 10.4.1 LAMEA Cat Vaccine Market by Component
Chapter 11. Company Profiles
- 11.1 Zoetis, Inc.
- 11.1.1 Company Overview
- 11.1.2 Financial Analysis
- 11.1.3 Regional Analysis
- 11.1.4 Research & Development Expenses
- 11.1.5 Recent strategies and developments:
- 11.1.5.1 Partnerships, Collaborations, and Agreements:
- 11.1.5.2 Product Launches and Product Expansions:
- 11.1.5.3 Acquisition and Mergers:
- 11.1.6 SWOT Analysis
- 11.2 Elanco Animal Health, Inc.
- 11.2.1 Company Overview
- 11.2.2 Financial Analysis
- 11.2.3 Regional Analysis
- 11.2.4 Research & Development Expenses
- 11.2.5 SWOT Analysis
- 11.3 Merck & Co., Inc.
- 11.3.1 Company Overview
- 11.3.2 Financial Analysis
- 11.3.3 Segmental and Regional Analysis
- 11.3.4 Research & Development Expenses
- 11.3.5 SWOT Analysis
- 11.4 Boehringer Ingelheim International GmbH
- 11.4.1 Company Overview
- 11.4.2 Financial Analysis
- 11.4.3 Regional & Segmental Analysis
- 11.4.4 Research & Development Expenses
- 11.4.5 Recent strategies and developments:
- 11.4.5.1 Trials and Approvals:
- 11.4.6 SWOT Analysis
- 11.5 Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- 11.5.1 Company Overview
- 11.5.2 SWOT Analysis
- 11.6 Virbac
- 11.6.1 Company Overview
- 11.6.2 Financial Analysis
- 11.6.3 Regional Analysis
- 11.6.4 Recent strategies and developments:
- 11.6.4.1 Acquisition and Mergers:
- 11.6.5 SWOT Analysis
- 11.7 Heska Corporation (Antech Diagnostics, Inc)
- 11.7.1 Company Overview
- 11.7.2 SWOT Analysis
- 11.8 Ceva Sante Animale
- 11.8.1 Company Overview
- 11.8.2 SWOT Analysis
- 11.9 Bioveta, a.s.
- 11.9.1 Company Overview






